Lilly’s Zyprexa injection probed by FDA after deaths
Eli Lilly and Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug.
Bloomberg News
Articles
Drugmakers may face ‘pay for delay’ suits, high court rules
Drug companies like Eli Lilly and Co. can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs.
Duke Energy names CFO to replace Rogers as chief exec
Former Indiana utility executive Jim Rogers, 65, agreed in November to step down under a settlement with North Carolina regulators.
U.S. unemployment rate rises despite jobs increase
Employment increased in May for retailers, construction companies, education and health services, leisure and hospitality businesses, and temporary-help agencies. Manufacturers, however, cut jobs for a third straight month.
NCAA wins dismissal of lawsuit over Sandusky fine
The lawsuit brought by Pennsylvania Gov. Tom Corbett failed to show a violation of federal antitrust law, U.S. District Judge Yvette Kane said in her decision throwing out the case.
Simon investors can proceed with CEO pay suit, judge rules
Simon Property Group Inc. investors can continue with a lawsuit in which company directors are accused of improperly raising CEO David Simon’s pay without shareholder approval, a judge ruled.
ExactTarget sale caps success story; CEO mum on Indy work force
ExactTarget CEO Scott Dorsey said the company will remain “very committed to Indianapolis” after its $2.5 billion buyout by tech giant Salesforce.com, but he would not comment on potential changes to the local work force of more than 1,000 employees.
Simon to buy $569M stake in European mall operator
Simon will gain an ownership stake in six McArthurGlen properties in Austria, the Netherlands, Italy and the United Kingdom, and become a partner in the London-based firm’s real estate management and development business.
Drug sold by Lilly tops Avastin in colon cancer survival study
Patients who got Erbitux together with chemotherapy as a first-line treatment lived about four months longer than those who got Avastin with chemotherapy, according to the 592-person study.
Paterno family sues NCAA over Penn State’s Sandusky fine
In a complaint filed Thursday, the family of the deceased coach and five members of the school’s board of trustees said the Indianapolis-based NCAA improperly interfered and grossly mishandled a criminal matter outside the scope of its authority.
WellPoint among 13 picked to join California exchange
California residents who choose to buy health insurance through the state exchange being created by the Affordable Care Act may end up paying higher premiums.
Stonegate raises $115M to fund jumbo mortgage expansion
The fast-growing Indianapolis-based firm will use the funds to fuel originations of loans not intended for government-backed programs, as well as to build its portfolio of servicing contracts, CEO Jim Cutillo said.
Sanctions against Penn State were necessary, NCAA tells judge
The National Collegiate Athletic Association’s sanctions against Pennsylvania State University for its role in the Jerry Sandusky sex-abuse scandal were needed to protect the integrity of intercollegiate sports, a lawyer for the Indianapolis-based association argued in court Monday.
Canada’s Supreme Court won’t hear Lilly appeal on Zyprexa
Eli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major developed countries.
National fraternities face more legal risk after court ruling
An Indiana appeals court ruling regarding the death of a Wabash College freshman may force national fraternities to take more responsibility for misconduct at chapter houses.
Lechleiter’s surgery to repair heart goes as planned
Eli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta is functioning as intended, the Indianapolis-based drugmaker said.
Three WellPoint directors step down, cite personal reasons
Lenox Baker, Sheila Burke and Susan Bayh resigned from the board effective immediately, Indianapolis-based WellPoint said Monday in a regulatory filing.
Lilly stops development on cancer drug after failed study
The drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual sales by 2018.
Duke Realty puts 17 Midwest office buildings on block
The developer is selling the buildings in Cincinnati, Cleveland and St. Louis to increase its emphasis on industrial properties. A research firm values them at $149 a square foot, or a total of about $350 million.
IU’s Kelley School of Business getting new dean
Idalene Kesner will be the first woman to lead the school, and one of only a small handful of female business school deans in the United States.